Company News

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health

MARLBOROUGH, Mass. 14 October--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global champion of women’s health, today announced that it has signed a definitive agreement to acquire Gynesonics, Inc. (Gynesonics®), a privately held medical device company focused on the development of minimally invasive solutions for women’s health for approximately $350 [...]

2024-10-15T07:16:02+01:00October 15th, 2024|All News, Company News|

Johnson & Johnson to Acquire V-Wave

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson1 (NYSE: JNJ) today announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. Under the terms of the agreement, Johnson & Johnson will acquire V-Wave for [...]

2024-08-20T16:07:22+01:00August 20th, 2024|All News, Company News, Investment|

Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon

SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"  Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. [...]

2024-08-12T21:21:27+01:00August 12th, 2024|All News, Company News, Investment, Medtech|

Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round

KIRKLAND, Wash. July 24, 2024 08:00 AM Eastern Daylight--(BUSINESS WIRE)-- Kestra Medical Technologies, Inc., a privately held wearable medical device and digital healthcare company, today announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with [...]

2024-07-29T17:05:17+01:00July 29th, 2024|All News, Company News, Investment, Medtech|

IntelyCare Appoints Industry Leader Matthew Levesque as CEO

QUINCY, Mass. July 10, 2024. IntelyCare, the healthcare industry’s most comprehensive nurse talent platform, today announced that it has appointed Matthew Levesque as the new Chief Executive Officer and member of the Board of Directors. A veteran healthcare executive known for scaling mission-driven organizations, Levesque will lead the expansion [...]

2024-07-18T21:03:23+01:00July 18th, 2024|All News, Company News|

Matthias Schupp appointed as CEO of Medartis

Basel, 9th July 2024. Medartis today announced that its Board has appointed Matthias Schupp to the position of CEO, joining Medartis by the beginning of November. Matthias will succeed Christoph Brönnimann, who will ensure a seamless transition. Matthias brings excellent knowledge of the global medical technology sector, having held [...]

2024-07-09T09:26:33+01:00July 9th, 2024|All News, Company News|

CeQur Simplicity™, a Wearable Mealtime Insulin Delivery Device, Obtains FDA-Clearance for 4 Days of Wear to Further Simplify Diabetes Management

The CeQur Simplicity patch is now FDA-cleared for up to 4 days of wear. Each patch replaces up to 12 injections further simplifying mealtime insulin management. Horw, Switzerland, June 18, 2024 - CeQur®, a medical device company dedicated to simplifying insulin delivery for individuals on multiple daily injections, announces [...]

2024-06-20T20:45:44+01:00June 20th, 2024|All News, Company News, Investment, Medtech|

SOPHiA GENETICS Announces Unilabs is Using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment Boston, MA and Rolle, Switzerland, April 17, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Unilabs, one of the [...]

2024-04-29T14:53:36+01:00April 17th, 2024|All News, Company News|

Miach Orthopaedics Raises $20 Million in Series B Extension

WESTBOROUGH, Massachusetts – April 2, 2024 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $20 million Series B extension financing round. The funds will support commercial [...]

2024-04-03T13:48:59+01:00April 3rd, 2024|All News, Company News, Medtech|
Go to Top